Keeping America's Edge Terminates Lobbying Contract with Chesapeake Enterprises Inc.

In a notable LDA contract termination, Keeping America's Edge has ended its lobbying relationship with Chesapeake Enterprises Inc., concluding a nearly year-long engagement focused on healthcare policy and NIH funding.

Why It Matters

The lobbying contract represented a significant financial commitment, with Keeping America's Edge spending $300,000 on advocacy efforts throughout 2025. For Chesapeake Enterprises Inc., this client accounted for approximately 49% of their quarterly lobbying revenue, making the termination a substantial loss.

Financial Breakdown - Total spending: $300,000 - Quarterly payments: - Q2 2025: $100,000 - Q3 2025: $100,000 - Q4 2025: $100,000

Interestingly, the organization has already engaged two additional lobbying firms:
- Miller Strategies LLC: $460,000 spent
- Venture Government Strategies LLC: $120,000 spent

Broader Context of Healthcare Advocacy

The termination comes at a critical moment in NIH funding discussions. The FY 2026 spending bill proposes $47.2-$48.7 billion for NIH, representing a modest 0.9% increase from the previous year. The bill actively protects key initiatives like ARPA-H, suggesting the lobbying efforts may have achieved their primary objectives.

LDA Contract End Implications The timing of the contract termination aligns closely with: - Pending Senate approval of the spending bill - A January 30 government funding deadline - Completion of initial advocacy goals around NIH funding

Who's Next: Lobbying Firm Transition

Miller Strategies LLC appears positioned to take the lead in continued advocacy. The firm brings significant experience with:
- Health care policy expertise
- Medical research lobbying
- Connections with key congressional committees

Lobbyist Lineup Key lobbyists now representing Keeping America's Edge: - Jeffrey Miller - Stephen Ruppel - Lucas J. Wallwork

Bottom Line

The LDA contract termination with Chesapeake Enterprises Inc. represents a strategic shift in Keeping America's Edge's lobbying approach. With multiple firms now engaged and a focused strategy on NIH funding, the organization appears committed to maintaining its advocacy momentum.

The organization's total lobbying investment across three firms now stands at $860,000, signaling a robust commitment to influencing healthcare policy and research funding.